Impact of Combined Medication and Behavioral Treatment in Young Children With Comorbid ASD and ADHD

Trial Profile

Impact of Combined Medication and Behavioral Treatment in Young Children With Comorbid ASD and ADHD

Not yet recruiting
Phase of Trial: Phase II

Latest Information Update: 13 Apr 2018

At a glance

  • Drugs Amphetamines (Primary)
  • Indications Attention-deficit hyperactivity disorder; Pervasive child development disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 05 Apr 2018 Planned initiation date changed from 1 Mar 2018 to 1 Apr 2018.
    • 04 Dec 2017 Planned initiation date changed from 1 Oct 2017 to 1 Mar 2018.
    • 10 Aug 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top